• S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

  • Feb 27 2021
  • Duración: 25 m
  • Podcast

S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors3 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will focus on chronic kidney disease (CKD) in patients with or without diabetes and treatment with sodium-glucose cotransporter 2 (SGLT-2) inhibitors. The bottom line is, how should these treatments be incorporated into clinical practice?
    Más Menos
activate_WEBCRO358_DT_T2
Más Menos

Lo que los oyentes dicen sobre S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles